Publication | Closed Access

KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer

Molecular PharmacologyBreast OncologyMedicineHormonal ReceptorReceptor Tyrosine KinaseCancer Cell BiologyBreast CancerPharmacologyCell BiologyMammary Gland DevelopmentEndocrine-related CancerPeptide Substrate Site